Requires health insurance and Medicaid coverage for testing and treatments to slow progression of Alzheimer's disease and related disorders.
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed Senate
- Passed General Assembly
- To Governor
- Became Law
Overview
This bill requires health insurance plans, including those offered to state employees and Medicaid recipients, to cover diagnostic testing and treatments designed to slow the progression of Alzheimer’s disease and related disorders. It mandates that these treatments must align with U.S. Food and Drug Administration guidelines and prohibits insurers from requiring ‘step therapy’ for these specific medications. The bill applies to various types of health insurance contracts and plans within New Jersey.
Bill text
Read the latest version inline or switch to a previous version.
Document of record
- Version
- Introduced
- Published
- Not published in the source record
This version is published only as a document. Open the viewer to read it here, or download the file.
Sponsors
Official sponsors from legislative records.
7 on record
Primary sponsors
Anthony Bucco
Cosponsors
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours